About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Radiomics for prEdiction of lunG cAncer biologY

Radiomics for prEdiction of lunG cAncer biologY

NCT05819905·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Poitiers University Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Histologically proven NSCLCC
pre treatment 18F FDG PET/CT
available molecular biology and histology results

You may not be if

non available PET/CT images

The record

StatusUnknown

PhaseNo phase

Taking part600

StartedJan 2023

UpdatedApr 19, 2023

Conditions

Non Small Cell Lung Cancer PET/CT PD-L1 Gene Mutation-Related Cancer

Where1

CHU Poitiers
Poitiers, France